CARROLL J MARTIN

ESPR

CARROLL J MARTIN serves as Director at Esperion Therapeutics, Inc. (ESPR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$77.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$77.0K

Companies Traded

ESPR

Active Period

Jun 2022 – May 2023

2 total trades

Most Recent

Buy ESPR

May 10, 2023 · $48.8K

CARROLL J MARTIN's Insider Trading at Esperion Therapeutics, Inc. (ESPR)

Buys

2 · $77.0K

Sells

0 · $0.00

Total Shares Bought

36,500

Total Shares Sold

ESPR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 10, 2023	Buy	31,500	$1.55	$48.8K	36,500
Jun 2, 2022	Buy	5,000	$5.64	$28.2K	5,000

Related Insiders

Benjamin Halladay

officer: Chief Financial Officer

ESPRSell · Mar 18, 2026

Sheldon L. Koenig

President and CEO

ESPRSell · Mar 18, 2026

Benjamin Looker

officer: General Counsel

ESPRSell · Mar 18, 2026

Explore More Insider Trading Data

ESPR Insider Trading Activity

View all insider trades at Esperion Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity